@dansfera: This is the *real* strategy big pharma uses! 🤯 Launching in the second-line setting first isn't just a fallback; it's a calculated regulatory hack. Think faster efficacy proof with a lower bar and smaller trials, making that massive investment for a first-line challenge seem so much more achievable later. A genius move for getting life-saving treatments to patients sooner. #BiotechStrategy #DrugApproval #PharmaHacks #ClinicalTrials #MedTok